Carlo Cammà

20PUBLICATIONS
129CO-AUTHORS
Liquid biopsiesPredictive and prognostic markersBehavioural epidemiologyMedical biochemistry - lipidsNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Nov 22, 2024
Early Hepatic Decompensation Identifies Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab or Sorafenib at Highest Risk of Death.

Giuseppe Cabibbo, Ciro Celsa, Salvatore Battaglia

|Aug 29, 2024
What is the benefit of prophylaxis to prevent HBV reactivation in HBsAg-negative anti-HBc-positive patients? Meta-analysis and decision curve analysis.

Ciro Celsa, Giacomo E M Rizzo, Gabriele Di Maria

|Aug 19, 2024
Clinical outcomes of MAFLD versus NAFLD: A meta-analysis of observational studies.

Grazia Pennisi, Giuseppe Infantino, Ciro Celsa

Pageof 4